³Ô¹Ï±¬ÁÏ
Skip to main content
³Ô¹Ï±¬ÁÏ
Campus status
Search the ³Ô¹Ï±¬ÁÏ website
Search
Jump to menu
Jump to...
News & Media
About ³Ô¹Ï±¬ÁÏ
Academics
Programs of study
Research & innovation
University life
Libraries
UTogether
A to Z Directory
News & Media
About ³Ô¹Ï±¬ÁÏ
Academics
Programs of study
Research & innovation
University life
Libraries
UTogether
A to Z Directory
Search the ³Ô¹Ï±¬ÁÏ website
Search
Main navigation
Future students
Current students
Alumni
Faculty and Staff
Convocation
³Ô¹Ï±¬ÁÏ
Campus status
Main navigation
Future students
Current students
Alumni
Faculty and Staff
Convocation
Jump to menu
Jump to...
News & Media
About ³Ô¹Ï±¬ÁÏ
Academics
Programs of study
Research & innovation
University life
Libraries
UTogether
A to Z Directory
News & Media
About ³Ô¹Ï±¬ÁÏ
Academics
Programs of study
Research & innovation
University life
Libraries
UTogether
A to Z Directory
³Ô¹Ï±¬ÁÏ menu
Latest news
Find a story
About ³Ô¹Ï±¬ÁÏ
The Bulletin Brief
Navigation
³Ô¹Ï±¬ÁÏ menu
Latest news
Find a story
About ³Ô¹Ï±¬ÁÏ
The Bulletin Brief
Joel Lexchin
News stories by Joel Lexchin
May 22, 2019
Health Canada committees risk financial conflicts of interest: ³Ô¹Ï±¬ÁÏ expert
January 15, 2019
Why Big Pharma must disclose payments to patient groups: ³Ô¹Ï±¬ÁÏ expert
October 25, 2018
³Ô¹Ï±¬ÁÏ expert on why we need answers to the thalidomide tragedy to ensure drug safety now
September 10, 2018
NAFTA negotiations may threaten pharmacare: ³Ô¹Ï±¬ÁÏ expert
September 5, 2018
³Ô¹Ï±¬ÁÏ expert on how drug ads leave Canadians in the dark about safety risks
July 5, 2018
What Big Pharma pays your doctor: ³Ô¹Ï±¬ÁÏ expert
March 19, 2018
³Ô¹Ï±¬ÁÏ expert on pharmacare and the 'chaotic world' of Canadian drug prices
